The observed alteration in BCL2 expression following lithium treatment is influenced by the choice of normalization method

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Odeya, Damri ^a,b   Galila, Agam ^a,b   Lilah, Toker ^c,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANKRD11 PROTEIN, HUMAN; LITHIUM DERIVATIVE; MARCKS PROTEIN; PROTEIN BCL 2; REPRESSOR PROTEIN;

ANIMAL; CELL LINE; CHICKEN; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; HUMAN; INFORMATION PROCESSING; METABOLISM; MOUSE; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; CELL LINE; CHICKENS; DATASETS AS TOPIC; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; LITHIUM COMPOUNDS; MICE; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

EID: 85045958598     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-24546-1     Document Type: Review

References (81)

1. Machado-Vieira, R., Manji, H. K. & Zarate, C. A. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11(Suppl 2), 92-109 (2009).
2. Chen, R. W. & Chuang, D. M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274, 6039-42 (1999).
3. Chen, G. et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72, 879-82 (1999).
4. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. & Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-6 (1990).
5. Chiu, C. T. & Chuang, D. M. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128, 281-304 (2010).
6. Levine, B., Sinha, S. & Kroemer, G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4, 600-6 (2008).
7. Sarkar, S. et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170, 1101-11 (2005).
8. Sade, Y. et al. IP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes. Transl. Psychiatry 6, e968 (2016).
9. Cohen, Y., Chetrit, A., Sirota, P. & Modan, B. Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Med Oncol 15, 32-6 (1998).
10. Hallas, J. et al. Cancer risk in long-term users of valproate: a population-based case-control study. Cancer Epidemiol Biomark. Prev 18, 1714-9 (2009).
11. Liu, J. J., Lin, M., Yu, J. Y., Liu, B. & Bao, J. K. Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 300, 105-14 (2010).
12. Del Bufalo, D., Biroccio, A., Leonetti, C. & Zupi, G. Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J 11, 947-53 (1997).
13. Placzek, W. J. et al. A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis 1, e40 (2010).
14. Damri, O. et al. Molecular effects of lithium are partially mimicked by inositol-monophosphatase (IMPA)1 knockout mice in a brain region-dependent manner. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 25, 425-434 (2015).
15. Cai, J. H. et al. Validation of rat reference genes for improved quantitative gene expression analysis using low density arrays. Biotechniques 42, 503-12 (2007).
16. Toker, L. et al. Inositol-related gene knockouts mimic lithium's effect on mitochondrial function. Neuropsychopharmacology 39, 319-28 (2013).
17. McQuillin, A., Rizig, M. & Gurling, H. M. D. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet. Genomics 17, 605-617 (2007).
18. Chetcuti, A., Adams, L. J., Mitchell, P. B. & Schofield, P. R. Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment. Psychiatr Genet 18, 64-72 (2008).
19. Seelan, R. S., Khalyfa, A., Lakshmanan, J., Casanova, M. F. & Parthasarathy, R. N. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience 151, 1184-97 (2008).
20. Fatemi, S. H., Reutiman, T. J. & Folsom, T. D. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder. Biochem Soc Trans 37, 1090-5 (2009).
21. Walasek, M. A. et al. The combination of valproic acid and lithium delays hematopoietic stem/progenitor cell differentiation. Blood 119, 3050-3059 (2012).
22. Linares, G. R. et al. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease. Exp. Neurol. 281, 81-92 (2016).
23. Lenox, R. H., Watson, D. G., Patel, J. & Ellis, J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res 570, 333-40 (1992).
24. Watson, D. G. & Lenox, R. H. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J Neurochem 67, 767-77 (1996).
25. Lenox, R. H. & Wang, L. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. Mol Psychiatry 8, 135-44 (2003).
26. Ghoshdastidar, D., Dutta, R. N. & Poddar, M. K. In vivo distribution of lithium in plasma and brain. Indian J Exp Biol 27, 950-4 (1989).
27. Alural, B., Ozerdem, A., Allmer, J., Genc, K. & Genc, S. Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells. Front. Cell. Neurosci. 9, 209 (2015).
28. Hiroi, T., Wei, H., Hough, C., Leeds, P. & Chuang, D.-M. Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J. 5, 102-111 (2005).
29. Plant, K. E. et al. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol. Appl. Pharmacol. 235, 124-134 (2009).
30. Son, H. et al. Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus. J. Neurochem. 85, 872-881 (2003).
31. Yu, I. T., Kim, J. S., Lee, S.-H., Lee, Y.-S. & Son, H. Chronic lithium enhances hippocampal long-term potentiation, but not neurogenesis, in the aged rat dentate gyrus. Biochem. Biophys. Res. Commun. 303, 1193-1198 (2003).
32. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N. & Manji, H. K. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75, 1729-34 (2000).
33. Hanson, N. D., Nemeroff, C. B. & Owens, M. J. Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus. J Pharmacol Exp Ther 337, 180-6 (2011).
34. Bernier, P. J. & Parent, A. Bcl-2 Protein as a Marker of Neuronal Immaturity in Postnatal Primate Brain. J. Neurosci. 18, 2486-2497 (1998).
35. Bush, A. L. & Hyson, R. L. Lithium increases bcl-2 expression in chick cochlear nucleus and protects against deafferentation-induced cell death. Neuroscience 138, 1341-1349 (2006).
36. Steward, O. & Rubel, E. W. Afferent influences on brain stem auditory nuclei of the chicken: Cessation of amino acid incorporation as an antecedent to age-dependent transneuronal degeneration. J. Comp. Neurol. 231, 385-395 (1985).
37. Wilkinson, B. L., Sadler, K. A. & Hyson, R. L. Rapid deafferentation-induced upregulation of bcl-2 mRNA in the chick cochlear nucleus. Brain Res. Mol. Brain Res. 99, 67-74 (2002).
38. McBride, E. G., Rubel, E. W. & Wang, Y. Afferent Regulation of Chicken Auditory Brainstem Neurons: Rapid Changes in Phosphorylation of Elongation Factor 2. J. Comp. Neurol. 521, 1165-1183 (2013).
39. Hizli, A. A. et al. Phosphorylation of Eukaryotic Elongation Factor 2 (eEF2) by Cyclin A-Cyclin-Dependent Kinase 2 Regulates Its Inhibition by eEF2 Kinase. Mol. Cell. Biol. 33, 596-604 (2013).
40. Karyo, R. et al. Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3. Mol. Cell. Neurosci. 45, 449-455 (2010).
41. Bangaru, M. L. Y., Park, F., Hudmon, A., McCallum, J. B. & Hogan, Q. H. Quantification of gene expression after painful nerve injury: validation of optimal reference genes. J. Mol. Neurosci. MN 46, 497-504 (2012).
42. Beasley, C. L. et al. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for diseaseassociated changes. Proteomics 6, 3414-25 (2006).
43. Behan, A. T., Byrne, C., Dunn, M. J., Cagney, G. & Cotter, D. R. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry 14, 601-13 (2009).
44. Focking, M. et al. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry 68, 477-88 (2011).
45. Bennett, G. S., Hollander, B. A., Laskowska, D. & DiLullo, C. Rapid degradation of newly synthesized tubulin in lithium-treated sensory neurons. J Neurochem 57, 130-9 (1991).
46. Bosetti, F. et al. Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull 57, 205-9 (2002).
47. Cannell, G. R., Bailey, M. J. & Dickinson, R. G. Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro. Life Sci 71, 2633-43 (2002).
48. Corena-McLeod Mdel, P. et al. Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression. Brain Res 1233, 8-19 (2008).
49. Nielsen, J. et al. Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 downregulation and cellular proliferation. Proc Natl Acad Sci U A 105, 3634-9 (2008).
50. Lakshmanan, J. et al. Proteomic analysis of rat prefrontal cortex after chronic lithium treatment. Proteomics Bioinforma. 5, 140-146 (2012).
51. Costain, W. J., Haqqani, A. S., Rasquinha, I., Giguere, M. S. & Slinn, J. Cerebral Ischemia Induced Proteomic Alterations: Consequences for the Synapse and Organelles. (In Tech, 2012).
52. He, C. & Klionsky, D. J. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43, 67-93 (2009).
53. Dengjel, J. et al. Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens. Mol Cell Proteomics 11(M111), 014035 (2012).
54. Powell, T. R. et al. Mood-stabilizers differentially affect housekeeping gene expression in human cells. Int. J. Methods Psychiatr. Res. 23, 279-288 (2014).
55. Huang, X., Wu, D.-Y., Chen, G., Manji, H. & Chen, D. F. Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism. Invest. Ophthalmol. Vis. Sci. 44, 347-354 (2003).
56. Keshavarz, M., Emamghoreishi, M., Nekooeian, A. A., J Warsh, J. & Zare, H. R. Increased bcl-2 Protein Levels in Rat Primary Astrocyte Culture Following Chronic Lithium Treatment. Iran. J. Med. Sci. 38, 255-262 (2013).
57. Lai, J. S., Zhao, C., Warsh, J. J. & Li, P. P. Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur. J. Pharmacol. 539, 18-26 (2006).
58. Valvassori, S. S. et al. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: [Mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway]. J. Psychiatr. Res. 65, 63-70 (2015).
59. Lowthert, L. et al. Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol Mood Anxiety Disord 2, 15 (2012).
60. Hruz, T. et al. RefGenes: identification of reliable and condition specific reference genes for RT-qPCR data normalization. BMC Genomics 12, 156 (2011).
61. Radonić, A. et al. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 313, 856-862 (2004).
62. Durrenberger, P. F. et al. Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study. Acta Neuropathol 124, 893-903 (2012).
63. Huggett, J., Dheda, K., Bustin, S. & Zumla, A. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 6, 279-284 (2005).
64. Beech, R. D. et al. Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). Pharmacogenomics J, https://doi.org/10.1038/tpj.2013.16 (2013).
65. Bas, A., Forsberg, G., Hammarström, S. & Hammarström, M.-L. Utility of the Housekeeping Genes 18S rRNA, β-Actin and Glyceraldehyde-3-Phosphate-Dehydrogenase for Normalization in Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction Analysis of Gene Expression in Human T Lymphocytes. Scand. J. Immunol. 59, 566-573 (2004).
66. Tricarico, C. et al. Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal. Biochem. 309, 293-300 (2002).
67. Corson, T. W., Woo, K. K., Li, P. P. & Warsh, J. J. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. Eur. Neuropsychopharmacol. 14, 143-150 (2004).
68. Cryns, K. et al. IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacology 33, 674-84 (2008).
69. O'Brien, W. T. et al. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J. Neurosci. Off. J. Soc. Neurosci. 24, 6791-6798 (2004).
70. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45 (2001).
71. Padmos, R. C. et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry 65, 395-407 (2008).
72. Kozera, B. & Rapacz, M. Reference genes in real-time PCR. J. Appl. Genet. 54, 391-406 (2013).
73. Quackenbush, J. Microarray data normalization and transformation. Nat Genet 32(Suppl), 496-501 (2002).
74. Zoubarev, A. et al. Gemma: a resource for the reuse, sharing and meta-analysis of expression profiling data. Bioinformatics 28, 2272-2273 (2012).
75. Schuettauf, F. et al. Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp. Eye Res. 83, 1128-1134 (2006).
76. Hammonds, M. D., Shim, S. S., Feng, P. & Calabrese, J. R. Effects of subchronic lithium treatment on levels of BDNF, Bcl-2 and phospho-CREB in the rat hippocampus. Basic Clin. Pharmacol. Toxicol. 100, 356-359 (2007).
77. Hammonds, M. D. & Shim, S. S. Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus. Basic Clin. Pharmacol. Toxicol. 105, 113-119 (2009).
78. Liechti, F. D. et al. The Mood-Stabilizer Lithium Prevents Hippocampal Apoptosis and Improves Spatial Memory in Experimental Meningitis. PLoS ONE 9, e113607 (2014).
79. Chen, W.-T., Huang, T.-L. & Tsai, M.-C. Bcl-2 associated with severity of manic symptoms in bipolar patients in a manic phase. Psychiatry Res. 225, 305-308 (2015).
80. Song, N. et al. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl- 2 expression in SH-SY5Y cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 38, 183-189 (2012).
81. McColl, G. et al. Pharmacogenetic Analysis of Lithium-induced Delayed Aging in Caenorhabditis elegans. J. Biol. Chem. 283, 350-357 (2008).